[3] The document is the result of extensive and lengthy collaboration between key stakeholders in the human drug compounding industry, including regulators, compounders, and health care professionals
Elite AU Peptides makes no medical, therapeutic, weight-loss, or body-composition claim about retatrutide, makes no claim that it is a substitute for or equivalent to any approved medicine, and does not supply tirzepatide
doi: 10.1038/nrcardio.2011.211 35 DegnKBBrockBJuhlCBDjurhuusCBGrubertJKimDet al
In the SURMOUNT-1 trial, tirzepatide at the highest dose (15 mg) produced average weight loss of 22.5% versus approximately 15% for semaglutide in comparable trials
IV hydration isnt simply a boutique therapy available only to the very wealthy or the very young
Improvements were also noted in waist circumference, blood pressure, fasting glucose, and lipid profiles